Investigating the effect of combined vaginal gel of oak placenta and fennel on sexual function and quality of sexual life of postmenopausal women

The effect of combined vaginal gel of Quercus brantii and fennel (Foeniculum vulgare) on the sexual function and quality of sexual life of menopausal women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240506061682N1

Enrollment

Registered

2024-06-19

Start date

2024-07-20

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of sexual life and sexual performance.

Interventions

Intervention 1: Intervention group: Each person received a 50-gram tube containing a combined herbal gel of oak (5.2%) and fennel (5%) with an applicator to be used for 8 weeks (one gram every night f

Eligibility

Sex/Gender

Female

Age

45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Passing at least one year since the last menstruation, having a hormone test with an FSH level greater than 40 international units age range of 45-65 years having sex and being monogamous

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Questionnaire score of sexual performance. Timepoint: At the beginning of the study and before drug administration and 8 weeks after the start of treatment. Method of measurement: Postmenopausal Women's Sexual Performance Questionnaire (FSFI).;Quality of sexual life of menopausal women. Timepoint: At the beginning of the study and before drug administration and 8 weeks after the start of treatment. Method of measurement: Women's Quality of Life Questionnaire (SQOL-F).	—

Measure

Time frame

Questionnaire score of sexual performance. Timepoint: At the beginning of the study and before drug administration and 8 weeks after the start of treatment. Method of measurement: Postmenopausal Women's Sexual Performance Questionnaire (FSFI).;Quality of sexual life of menopausal women. Timepoint: At the beginning of the study and before drug administration and 8 weeks after the start of treatment. Method of measurement: Women's Quality of Life Questionnaire (SQOL-F).

—

Secondary

Measure	Time frame
Sexual desire. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Orgasm. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Stimulation. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Get wet. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Satisfaction. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;The pain. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.	—

Measure

Time frame

Sexual desire. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Orgasm. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Stimulation. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Get wet. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;Satisfaction. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.;The pain. Timepoint: At the beginning of the study before drug administration and also after treatment. Method of measurement: Questionnaire of sexual function of postmenopausal women.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Nikkhah

Yasouj University of Medical Sciences

saranik358@gmail.com+98 917 664 8896

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026